On p. 1068 of the November 2002 issue (Nat. Biotechnol. 20, 1068; 2002), the Business and Regulatory News Analysis story “US panel advises resumption of gene trials,” contains an error. The “US Recombinant DNA Advisory Council” should be the “FDA Biological Response Modifiers Advisory Committee”. Nature Biotechnology regrets the error.
The online version of the original article can be found at 10.1038/nbt1102-1068